• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Articles published by NextCure

    NextCure Provides Business Update and Reports Third Quarter 2024 Financial Results
    From NextCure
    Via GlobeNewswire
    Tickers NXTC
    NextCure Reports Preclinical Data for LNCB74 and Additional Clinical Biomarker Data for NC410 Combo at Society for Immunotherapy of Cancer Annual Meeting
    From NextCure
    Via GlobeNewswire
    Tickers NXTC
    NextCure to Give Two Presentations at Society for Immunotherapy of Cancer Annual Meeting
    From NextCure
    Via GlobeNewswire
    Tickers NXTC
    NextCure Presented Results of the Phase 1b Study of NC410 in Combination with Pembrolizumab at ESMO 2024
    From NextCure
    Via GlobeNewswire
    Tickers NXTC
    NextCure Provides Business Update and Reports Second Quarter 2024 Financial Results
    From NextCure
    Via GlobeNewswire
    Tickers NXTC
    NextCure to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
    From NextCure
    Via GlobeNewswire
    Tickers NXTC
    NextCure Presents Phase 1b Data on NC410 and Pembrolizumab Combination at ASCO 2024
    From NextCure
    Via GlobeNewswire
    Tickers NXTC
    NextCure Provides Business Update and Reports First Quarter 2024 Financial Results
    From NextCure
    Via GlobeNewswire
    Tickers NXTC
    NextCure to Present Phase 1b Data of NC410 in Combination with Pembrolizumab at ASCO 2024
    From NextCure
    Via GlobeNewswire
    Tickers NXTC
    NextCure and LCB Present Preclinical Data on B7-H4 Antibody Drug Conjugate at AACR 2024
    From NextCure
    Via GlobeNewswire
    Tickers NXTC
    NextCure Appoints Dr. Rakesh Dixit to Scientific Advisory Board
    From NextCure
    Via GlobeNewswire
    Tickers NXTC
    NextCure to Present at 23rd Annual Needham Virtual Healthcare Conference
    From NextCure
    Via GlobeNewswire
    Tickers NXTC
    NextCure Provides Business Update and Reports Full Year 2023 Financial Results
    From NextCure
    Via GlobeNewswire
    Tickers NXTC
    NextCure Publishes Preclinical Data Demonstrating Function of FLRT3 as a T Cell Inhibitor in Science Advances
    From NextCure
    Via GlobeNewswire
    Tickers NXTC
    NextCure Presents Preclinical Data on a Novel Therapeutic Candidate Targeting VSTM-1 for the Treatment of Progressive Inflammatory Airway Disorders
    From NextCure
    Via GlobeNewswire
    Tickers NXTC
    NextCure Publishes Non-Clinical Data Demonstrating Anti-Siglec-15 Treatment Prevented Bone Loss Due to Immobilization from Acute Spinal Cord Injury
    From NextCure
    Via GlobeNewswire
    Tickers NXTC
    NextCure Provides Year-End Clinical Pipeline Updates
    From NextCure
    Via GlobeNewswire
    Tickers NXTC
    NextCure to Present at the 35th Annual Piper Sandler Healthcare Conference
    From NextCure
    Via GlobeNewswire
    Tickers NXTC
    NextCure Publishes Non-Clinical Data Defining the Mechanism of Action for NC525, a Novel LAIR-1 Antibody for AML
    From NextCure
    Via GlobeNewswire
    Tickers NXTC
    NextCure Provides Business Update and Reports Third Quarter 2023 Financial Results
    From NextCure
    Via GlobeNewswire
    Tickers NXTC
    Preclinical Data Demonstrate Anti-Siglec-15 Treatment Reduced Bone Loss and Enhanced Bone Quality in Mice with Moderate-to-Severe Osteogenesis Imperfecta (OI)
    From NextCure
    Via GlobeNewswire
    Tickers NXTC
    NextCure Presents Preclinical Data on NC181, a Novel Therapeutic Candidate Targeting ApoE4, for the Treatment of Alzheimer’s Disease
    From NextCure
    Via GlobeNewswire
    Tickers NXTC
    A Phase 2 Study of Anti-Siglec-15 Antibody, NC318, in Combination with Pembrolizumab (NCT04699123) Demonstrates Clinical Activity in Patients with Advanced PD-1 Axis Inhibitor Refractory NSCLC
    From NextCure
    Via GlobeNewswire
    Tickers NXTC
    NextCure and Nordic Bioscience Publish Review Article on the Regulation of Tumor Immunity by Tumor Collagen
    From NextCure
    Via GlobeNewswire
    Tickers NXTC
    Preclinical Data Demonstrate Potential Application of Anti-Siglec-15 Treatment in Bone Disease
    From NextCure
    Via GlobeNewswire
    Tickers NXTC
    NextCure to Present at the H.C. Wainwright 25th Annual Global Investment Conference
    From NextCure
    Via GlobeNewswire
    Tickers NXTC
    NextCure Provides Business Update and Reports Second Quarter 2023 Financial Results
    From NextCure
    Via GlobeNewswire
    Tickers NXTC
    NextCure Presents Non-Clinical Data Defining the Mechanism of NC525 at the 2023 Federation of Clinical Immunology Societies (FOCIS) Annual Meeting
    From NextCure
    Via GlobeNewswire
    Tickers NXTC
    NextCure to Present at the JMP Securities Life Sciences Conference
    From NextCure
    Via GlobeNewswire
    Tickers NXTC
    NextCure Provides Business Update and Reports First Quarter 2023 Financial Results
    From NextCure
    Via GlobeNewswire
    Tickers NXTC
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.